Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone plus sildenafil for persistent pulmonary hypertension in neonates
PACTR201902691230243Completed
- Sponsor
- Alexandria University
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sildenafil and milrinone in persistent pulmonary hypertension of the newborn (PPHN) (3 arms), sponsored by Alexandria University. Primary endpoint: Improvement of pulmonary artery systolic pressure. Started Apr 2018; status: completed.
02
Drugs
sildenafilmilrinone
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on PACTR201902691230243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201902691230243.